Back
Day Range
$202.26
$207.23
52-Week Range
$109.82
$247.21
Volume
754,318
50D / 200D Avg
$213.36
/
$194.00
Prev Close
$200.35
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.7 | 0.4 |
| P/B | 4.2 | 2.9 |
| ROE % | 33.5 | 3.7 |
| Net Margin % | 6.6 | 3.8 |
| Rev Growth 5Y % | 2.3 | 10.0 |
| D/E | 3.1 | 0.2 |
Key Takeaways
Revenue grew 2.26% annually over 5 years — modest growth
Earnings declined -56.03% over the past year
ROE of 33.54% indicates high profitability
Debt/Equity of 3.12 — high leverage
Generating 2.53B in free cash flow
P/E of 12.71 — trading at a low valuation
Growth
Revenue Growth (5Y)
2.26%
Revenue (1Y)3.12%
Earnings (1Y)-56.03%
FCF Growth (3Y)24.85%
Quality
Return on Equity
33.54%
ROIC15.13%
Net Margin6.60%
Op. Margin16.46%
Safety
Debt / Equity
3.12
Current Ratio1.76
Interest Coverage0.00
Valuation
P/E Ratio
12.71
P/B Ratio4.24
EV/EBITDA8.03
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.12% | Revenue Growth (3Y) | 1.84% |
| Earnings Growth (1Y) | -56.03% | Earnings Growth (3Y) | 51.75% |
| Revenue Growth (5Y) | 2.26% | Earnings Growth (5Y) | 11.39% |
| Profitability | |||
| Revenue (TTM) | 21.31B | Net Income (TTM) | 1.41B |
| ROE | 33.54% | ROA | 4.74% |
| Gross Margin | 41.41% | Operating Margin | 16.46% |
| Net Margin | 6.60% | Free Cash Flow (TTM) | 2.53B |
| ROIC | 15.13% | FCF Growth (3Y) | 24.85% |
| Safety | |||
| Debt / Equity | 3.12 | Current Ratio | 1.76 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 12.71 | P/B Ratio | 4.24 |
| P/S Ratio | 0.84 | PEG Ratio | -0.24 |
| EV/EBITDA | 8.03 | Dividend Yield | 0.00% |
| Market Cap | 17.88B | Enterprise Value | 28.16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21.31B | 20.67B | 20.55B | 19.17B | 19.49B |
| Net Income | 1.41B | 3.20B | 611.00M | 411.00M | 914.00M |
| EPS (Diluted) | 15.49 | 32.70 | 5.71 | 3.79 | 8.42 |
| Gross Profit | 8.83B | 8.21B | 7.81B | 7.05B | 7.27B |
| Operating Income | 3.51B | 5.96B | 2.51B | 2.33B | 2.87B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29.68B | 28.94B | 28.31B | 27.16B | 27.58B |
| Total Liabilities | 20.70B | 20.39B | 22.80B | 22.55B | 23.32B |
| Shareholders' Equity | 4.22B | 4.17B | 1.61B | 1.14B | 1.03B |
| Total Debt | 13.17B | 14.33B | 15.00B | 15.08B | 15.65B |
| Cash & Equivalents | 2.88B | 3.02B | 1.23B | 858.00M | 2.36B |
| Current Assets | 7.85B | 7.68B | 7.17B | 5.98B | 7.08B |
| Current Liabilities | 4.46B | 4.31B | 4.76B | 4.48B | 5.11B |